R/R LBCL: A Practical Guide to CAR T Referral and Coordination

Guest: Loretta J. Nastoupil, MD Guest: Manali Kamdar, MD CAR T cell therapy has been established as a standard-of-care option in the second-line setting for appropriate relapsed/refractory patients with large B-cell lymphoma (LBCL). 1 Some outcomes data suggest more favorable outcomes when CAR T is used in the second-line setting compared with subsequent lines of therapy. 2,3 That’s why it’s…

Read the original on reachmd.com ↗